Program Outline - mortonkernmd.com

advertisement

UC Irvine Cath Lab Essentials

Program - 2015

Presented by

University of California, Irvine

School of Medicine

Division of Cardiology

January 24, 2015

UC Irvine

Cath Lab Essentials Program - 2015

Doubletree Hotel Anaheim/Orange County

100 The City Drive, Orange, CA

______________________________________________________________________________

Course Description

The UCI Cath Lab Essentials Program is designed to expand upon and fill knowledge gaps brought to the attention of the cath lab faculty by the nurses and staff working in the cath lab. Cath lab nurses/staff require periodic updates on procedure techniques, basic hemodynamics, cardiovascular pathophysiology, angiography, and novel interventional procedures in this dynamic and changing field. The Society of

Invasive Cardiac Professionals recommends periodic updates on current and new cath lab techniques and equipment.

Learning Objectives:

At the conclusion of this activity the participant should be able to:

1.

Obtain a basic understanding of hemodynamics in the cardiac Cath Lab, identify pressure measurement, artifacts and the application of pressure waveforms to the diagnosis of valvular abnormalities.

2.

Review the indications and contraindications for cardiac catheterization, identify complications and their management and understand the use of transfemoral and transradial catheterization techniques.

3.

Identify new methods for interventional cardiology procedures, the use of hemodynamic support devices, coronary stents, fractional flow reserve (FFR), intravascular ultrasound (IVUS) and optical coherence tomography (OCT).

Target Audience : Catheterization lab nurses and technicians, cardiovascular nurses, and students and fellows-in-training and local community hospital physicians.

Accreditation Statement : The University of California, Irvine School of Medicine, is accredited by the

Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement : The University of California, Irvine School of Medicine designates this live activity for a maximum of 6 AMA PRA Category 1 Credits

TM

. Physicians should only claim credit commensurate with the extent of their participation in the activity. ASRT Designation : The

American Society of Radiologic Technologists (ASRT) has approved this live activity for a maximum of

7 Category A Credits. Participants must complete the entire activity as designed and approvd to earn the credit. Disclosure Statement: It is the policy of the University of California, Irvine School of Medicine and the University of California CME Consortium to ensure balance, independence, objectivity and scientific rigor in all CME activities. Full disclosure of conflict resolution will be made in writing via handout materials or syllabus.

California Assembly Bill 1195

This activity is in compliance with California Assembly Bill 1195, which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. For specific information regarding Bill 1195 and definitions of cultural and linguistic competency, please visit the CME website at www.cme.uci.edu

.

SYLLABUS DISCLOSURE

UC IRVINE CATH LAB ESEENTIALS PROGRAM - 2015

All faculty presenting at activities certified for CME must complete the Faculty Disclosure form regardless of whether or not the activity is receiving commercial support. Documentation of disclosures to participants is required in this format.

UCI OCME requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. Planning must be free of the influence or control of a commercial entity, and promote improvements or quality in healthcare. It is the policy of the UCI Office of Continuing Medical Education to insure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty participating in UCI OCME sponsored CME programs are expected to disclose to the activity participants any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education activity. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the course content. The intent of this policy is identifying potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. It remains for the participants to determine whether the speaker’s outside interests reflect a possible bias in either the exposition or the conclusions presented.

Speaker Name Conflict Resolution

Morton J. Kern, MD

Pranav Patel, MD

Name of Commercial

Interest

ACIST Medical Systems

OPSENS

VolcanoTherapeutics

St. Jude Medical

Nature of Relevant

Relationship

Consultant

Consultant

Speaker

Speaker

N/A

As course director, I will to the best of my ability ensure that content is independent of commercial bias. Presentation has been peer reviewed for evidence base and fair balance. Will not discuss the use of any unlabelled/ unapproved drugs or devices.

Rajesh Banker, MD

Teferi Mitiku, MD

Alice Perlowski, MD

Arnold Seto, MD

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

This educational activity may contain discussion of unlabeled and/or investigational uses of agents that are not approved by the FDA. Please consult the prescribing information for each product.

Speaker Name

Morton J. Kern, MD

Pranav Patel, MD

Rajesh Banker, MD

Teferi Mitiku, MD

Alice Perlowski, MD

Arnold Seto, MD

Product

None

None

None

None

None

None

Product Use

The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views of the University of California, Irvine School of Medicine.

Program Faculty

____________________________________________________________________________________

COURSE CHAIRS

Morton J. Kern, MD

Professor of Medicine

Chief, Department of Medicine, LBVA

Associate Chief, Division of Cardiology, UCI

Pranav M. Patel, MD

Associate Professor of Medicine

Chief, Division of Cardiology

Director, Cardiac Catheterization Laboratory

University of California, Irvine

UCI – SCHOOL OF MEDICINE FACULTY

Arnold Seto, MD, MPH

Assistant Professor of Medicine

Interim Chief, Cardiology, LBVA

Interventional Cardiologist, LBVA and UCI

Teferi Mitiku, MD

Assistant Professor of Medicine

Electrophysiologist

University of California, Irvine

Alice Perlowski, MD

Assistant Professor of Medicine

Interventional Cardiologist, LBVA and UCI

Rajesh Banker, MD

Assistant Professor of Medicine

Electrophysiologist

University of California, Irvine

UC Irvine Cath Lab Essential Program - 2015

January 24, 2015

DoubleTree Hotel

07:30-07:55 Registration with Coffee and Danish

Meet and Greet Faculty

07:55-08:00 Welcome Remarks

08:00-08:30 Patient Preparation, Safety, and Post Procedure Care

Kern

Seto

08:30-09:00 Coronary Angiography: Coronary Anatomy,

Anomalies and the Ventricular Angiograms

Kern

09:00-09:30 ECG and Arrhythmia in STEMI:

What You Should Know

Mitiku

09:30-10:00 Essential Skills: Understanding Access and Perlowski

Approach to PAD

10:00-10:15 Break

10:15-10:45 IVUS, OCT and NIRS: Different Views of

Atherosclerosis

Patel

10:45-11:15 Coronary Stenting: The Appropriate use of FFR

11:15-11:45 Hemodynamics for the Cath Lab and ICU

11:45-12:30 Lunch

12:30-1:00

1:00-1:30

Advanced Hemodynamics: Essentials for TAVR Perlowski and Mitral Valve Disease

Essentials for Pacemakers and ICDs

Kern

Seto

Banker

1:30-2:00

2:00-3:00

3:00

LV Assist Devices for Hemodynamic Support:

IABP, Impella, Tandem Heart

Case Review and Complications: Kern/Patel

Presentations from Cath Lab Staff and Physicians

Adjourn

Patel

Download